Neuraxis Net Income From Continuing Ops from 2010 to 2026

NRXS Stock   4.54  0.03  0.67%   
Neuraxis Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to about -7.8 M in 2026. From the period from 2010 to 2026, Neuraxis Net Loss quarterly data regression had mean square error of 5.9 T and mean deviation of  2,074,573. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-7.4 M
Current Value
-7.8 M
Quarterly Volatility
2.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Neuraxis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuraxis' main balance sheet or income statement drivers, such as Interest Income of 0.0, Depreciation And Amortization of 41.4 K or Interest Expense of 328.5 K, as well as many indicators such as Price To Sales Ratio of 13.27, Dividend Yield of 0.0 or PTB Ratio of 7.43. Neuraxis financial statements analysis is a perfect complement when working with Neuraxis Valuation or Volatility modules.
  
Build AI portfolio with Neuraxis Stock
Check out the analysis of Neuraxis Correlation against competitors.
For more information on how to buy Neuraxis Stock please use our How to Invest in Neuraxis guide.

Latest Neuraxis' Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Neuraxis over the last few years. It is Neuraxis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neuraxis' overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Neuraxis Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(5,109,970)
Coefficient Of Variation(57.55)
Mean Deviation2,074,573
Median(3,726,149)
Standard Deviation2,940,867
Sample Variance8.6T
Range11.6M
R-Value(0.60)
Mean Square Error5.9T
R-Squared0.36
Significance0.01
Slope(348,164)
Total Sum of Squares138.4T

Neuraxis Net Income From Continuing Ops History

2026-7.8 M
2025-7.4 M
2024-8.2 M
2023-14.6 M
2022-4.8 M
2021-3 M

About Neuraxis Financial Statements

Neuraxis shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Neuraxis investors may analyze each financial statement separately, they are all interrelated. The changes in Neuraxis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Neuraxis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-7.4 M-7.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Neuraxis Stock Analysis

When running Neuraxis' price analysis, check to measure Neuraxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuraxis is operating at the current time. Most of Neuraxis' value examination focuses on studying past and present price action to predict the probability of Neuraxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuraxis' price. Additionally, you may evaluate how the addition of Neuraxis to your portfolios can decrease your overall portfolio volatility.